Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 27 of 31

COMPLETED Phase 4

MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine

NCT00809055

COMPLETED

Study of the Effect of Inhaled Anesthetics on Diastolic Heart Function Using a Doppler-derived Efficiency Index

NCT00907439

COMPLETED

Glycemic Control, Brain Structure and Cognition in Youth With Type 1 Diabetes (T1DM)

NCT00879203

TERMINATED NA

Step Down Colon Cancer Risk

NCT01476631

COMPLETED Phase 2

The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics

NCT00784459

COMPLETED Phase 1

A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors

NCT00869388

COMPLETED NA

Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet

NCT00763087

COMPLETED NA

Educating Missouri Patients About Preemptive Living Donor Transplantation

NCT01048437

COMPLETED NA

Comparison of Double Wire Technique With Pancreatic Duct Stent Placement for Difficult Bile Duct Cannulation

NCT00919074

COMPLETED Phase 1

Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)

NCT00795288

COMPLETED NA

Systems of Care for New Moms: Integrating Depression Treatment

NCT01407783

COMPLETED NA

Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study

NCT00907140

COMPLETED NA

Telephone Coaches to Improve Control of Asthma in Children ( PARTNER) Study)

NCT00860834

COMPLETED

Prospective Database of Gastrointestinal Stromal Cell Tumors (GISTs)

NCT02147145

COMPLETED

Sapropterin in Individuals With Phenylketonuria

NCT00730080

COMPLETED

Urine Proteome of Patients Having Surgery

NCT00851994

COMPLETED NA

Staphylococcus Aureus Decolonization Study

NCT00731783

COMPLETED NA

A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)

NCT00853164

COMPLETED Phase 2

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

NCT00671437

COMPLETED Phase 1

LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

NCT00691938

COMPLETED NA

Collaborative Research Group for Necrotizing Enterocolitis

NCT00828451

COMPLETED Phase 1

Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia

NCT00671697

COMPLETED Phase 2

Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma

NCT00868192

TERMINATED Early Phase 1

The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease

NCT00762814

COMPLETED

Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma

NCT01880008

COMPLETED Early Phase 1

Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease

NCT00797056

COMPLETED Phase 1

Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies

NCT00703625

COMPLETED Phase 1

Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies

NCT00703170

COMPLETED Phase 4

Study Evaluating Whether the Bispectral Index Prevents Patients at Higher Risk From Being Awake During Surgery and Anesthesia

NCT00682825

COMPLETED

Synthetic Mesh Explant Study

NCT01880021

TERMINATED NA

A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain

NCT00802659

COMPLETED NA

Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity

NCT00603603

COMPLETED NA

Vitamins in Nitrous Oxide Study

NCT00655980

COMPLETED

Tissue Penetration of Antibiotics in Obesity

NCT00752908

COMPLETED NA

Effect of Endoplasmic Reticulum Stress on Metabolic Function

NCT00771901

COMPLETED Phase 1

Intensity Modulated Radiotherapy for Breast Cancer

NCT00594477

COMPLETED NA

Methadone in Pediatric and Adult Sickle Cell Patients

NCT00761085

COMPLETED Phase 2

Collaborative Tinnitus Research at Washington University

NCT00567892

COMPLETED Phase 1

Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass

NCT00585013

COMPLETED NA

Impact of a Neonatal-Bereavement-Support DVD on Grief

NCT01926080

COMPLETED NA

Sodium Thiosulfate Treatment of Vascular Calcification in ESRD

NCT00568399

TERMINATED Phase 2

Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer

NCT00603408

COMPLETED Phase 1

A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00555256

COMPLETED

Imaging Cardiac Electrical Remodeling With Electrocardiogram Imaging (ECGI)

NCT00785564

COMPLETED

Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease

NCT00725309

COMPLETED Phase 1

Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage

NCT00968227

COMPLETED

Genetic Regulation of Surfactant Deficiency

NCT00828243

COMPLETED NA

Post-op Rehabilitation's Influence on Tendon Healing & Clinical Outcomes Following Arthroscopic Rotator Cuff Repair

NCT00756015

TERMINATED Phase 2

Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation

NCT00593645

COMPLETED

Factors That Affect the Development of COPD Symptoms

NCT00740337

← Previous Page 27 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.